Post-traumatic stress disorder (PTSD) affects 7.7 million Americans. One diagnostic criterion for PTSD is avoidance of stimuli that are related to the traumatic stress. Using a predator odor stress conditioned place aversion (CPA) model, rats can be divided into groups based on stress reactivity, as measured by avoidance of the odor-paired context. Avoider rats, which show high stress reactivity, exhibit persistent avoidance of stress-paired context and escalated alcohol drinking. Here, we examined the potential role of corticotropin-releasing factor (CRF), a neuropeptide that promotes anxiety-like behavior in mediating avoidance and escalated alcohol drinking after stress. CRF is expressed in the medial prefrontal cortex (mPFC). The dorsal and ventral sub-regions of the mPFC (dmPFC and vmPFC) have opposing roles in stress reactivity and alcohol drinking. We hypothesized that vmPFC CRF-CRFR1 signaling contributes functionally to stress-induced avoidance and escalated alcohol self-administration. In Experiment 1, adult male Wistar rats were exposed to predator odor stress in a CPA paradigm, indexed for avoidance of odor-paired context, and brains processed for CRF-immunoreactive cell density in vmPFC and dmPFC. Post-stress, Avoiders exhibited higher CRF cell density in vmPFC, but not the dmPFC. In Experiment 2, rats were tested for avoidance of a context repeatedly paired with intra-vmPFC CRF infusions. In Experiment 3, rats were stressed and indexed, then tested for the effects of intra-vmPFC CRFR1 antagonism on avoidance and alcohol self-administration. Intra-vmPFC CRF infusion produced avoidance of a paired context, and intra-vmPFC CRFR1 antagonism reversed avoidance of a stress-paired context, but did not alter post-stress alcohol self-administration. These findings suggest that vmPFC CRF-CRFR1 signaling mediates avoidance of stimuli paired with traumatic stress.
Introduction
Traumatic stress disorders (e.g. post-traumatic stress disorder; PTSD) affect 7.7 million Americans (NIH MedlinePlus, 2009 ). Major diagnostic criteria for PTSD include re-experiencing the traumatic event, increased arousal, negative affective state, and persistent avoidance of stimuli that are related to the traumatic stress (American Psychiatric Association, 2013) . Additionally, approximately 22e43% of PTSD patients meet diagnostic criteria for alcohol use disorder (AUD; Blanco et al., 2013) .
Persistent avoidance of stimuli that are related or perceived to be related to the traumatic stress is a major diagnostic criterion for PTSD in humans (American Psychiatric Association, 2013) , and avoidance of trauma-related stimuli predicts subsequent onset of PTSD symptoms (Shin et al., 2015) . Our lab uses a predator odor model of PTSD in which rats are divided into groups based on their stress reactivity, as indexed by avoidance of a predator odor-paired chamber (i.e., Avoiders and Non-Avoiders; Edwards et al., 2013) . Using this model, our lab has previously shown that predator odor stress produces persistent avoidance of the predator odor-paired stimuli in a proportion of the animals (i.e., Avoiders). These animals also escalate alcohol self-administration after stress (Edwards et al., 2013) . Interestingly, these post-stress differences do not appear to be caused by differences in learning and memory. NonAvoiders show no differences in appetitive conditioning and are able to acquire operant conditioning at the same rate as Avoiders prior to stress exposure (Edwards et al., 2013) . Furthermore, these animals do not differ in baseline alcohol self-administration, anxiety-like behavior (Edwards et al., 2013) , or nociception (Itoga et al., in press) prior to stress.
Corticotropin-releasing factor (CRF) mediates affective regulation and arousal after stress (Heinrichs and Koob, 2004) . In addition to activating the hypothalamic-pituitary-adrenal (HPA) axis, CRF acts as a neuromodulator in extra-hypothalamic areas of the brain including the prefrontal cortex (PFC) and the extended amygdala (Koob and Heinrichs, 1999) . Brain CRF is dysregulated in psychiatric disorders including anxiety disorders, depression, and drug use disorders (George and Koob, 2010) . Central administration of CRF increases anxiety-like behaviors and autonomic stress responses (Dunn and Berridge, 1990; Fisher, 1989) , and produces conditioned place aversion (Cador et al., 1992) . CRF1 receptors (CRFR1) mediate anxiety-like behavior and hyperarousal in stressed rats (Heinrichs and Koob, 2004; Roltsch et al., 2014) . In addition, CRFR1s mediate binge-like ethanol consumption in mice (Lowery-Gionta et al., 2012) and post-stress and post-dependent escalations in alcohol drinking in mice and rats (Lowery et al., 2007; Sommer et al., 2008) . Prior work from our lab showed that systemic antagonism of CRFR1s reduces hyperalgesia, hyperarousal, and alcohol selfadministration in stressed rats (Roltsch et al., 2014) .
The medial PFC (mPFC) has a major role in cognitive and emotional regulation, and the mPFC sends highly organized efferent projections to sub-cortical regions important for affective and motivated behaviors. The mPFC exerts top-down regulation of subcortical sites that coordinate stress responses, including the extended amygdala, the paraventricular nucleus of the hypothalamus, and the dorsal raphe nucleus (Sotres-Bayon and Quirk, 2010; George and Koob, 2010) . Medial PFC projections to basolateral and central amygdala (CeA) are important for fear conditioning (SotresBayon and Quirk, 2010) and are disrupted during alcohol withdrawal (George et al., 2012) .
The dmPFC and vmPFC have opposing roles in various behaviors. For example, the dmPFC promotes fear learning and fear expression through its connections with the basolateral amgydala (BLA), and the vmPFC promotes fear extinction through connections with the intercalated cells, CeA, and/or basomedial amygdala (Sotres-Bayon and Quirk, 2010; Adhikari et al., 2015) . Similarly, the dmPFC inhibits hypothalamic stress responses (Radley et al., 2006) , whereas the vmPFC facilitates hypothalamic stress responses (Radley et al., 2006) . Past work from our lab showed that Avoider rats have increased activation, as measured by ERK phosphorylation, of the vmPFC, but not the dmPFC, following a stress reminder (Edwards et al., 2013) . Furthermore, human imaging studies demonstrate that lesions of the vmPFC significantly decrease PTSD symptoms, suggesting a critical role for vmPFC in development of PTSD following traumatic stress (Koenigs et al., 2008) .
Recent studies demonstrate a role for CRF in the mPFC in mediating anxiety-like behavior (Miguel et al., 2014; Pentkowski et al., 2013) . Specifically, low CRF doses infused into the mPFC increase anxiety-like behavior, while higher doses decrease anxietylike behavior (Ohata and Shibasaki, 2011; Jaferi and Bhatnagar, 2007; Pentkowski et al., 2013) . It is also worth noting that a recent study reports a role for CRF-CRFR1-PKA signaling in the mPFC in acute stress-induced executive dysfunction (Uribe-Mariño et al., 2016) . Importantly, these studies examined the mPFC as a whole, but here we tested the effects of stress on CRF in vmPFC and dmPFC, due largely to their different afferents, efferents, and assigned functions (Heidbreder and Groenewegen, 2003) .
The purpose of the current studies was to determine the effect of predator odor stress on CRF cell density in mPFC sub-regions, to assess the aversive properties of CRF in vmPFC, and to determine the role of CRF-CRFR1 signaling in avoidance of predator odorpaired stimuli and post-stress alcohol self-administration. We hypothesized that 1) predator odor stress would increase the density of CRF-immunoreactive (CRF-ir) cells in vmPFC of Avoiders, 2) CRF infusions into vmPFC would produce a conditioned place aversion (CPA) in rats, 3) CRFR1 antagonism in vmPFC would abolish avoidance of a predator odor-paired context, and finally that 4) Avoiders would exhibit increased alcohol self-administration that would be reversed by CRFR1 antagonism in vmPFC.
Methods and materials
2.1. General methods 2.1.1. Animals Specific-pathogen free adult male Wistar rats (N ¼ 152) (Charles River) weighing 225e250 g at the time of arrival were housed in groups of two in a humidity-and temperature-controlled (22 C) vivarium on a 12 h light/12 h dark cycle (lights off at 8 a.m.). Animals had ad libitum access to food and water throughout experiments. Rats were acclimated for one week before start of experiments and were handled daily prior to initiation of surgical and experimental protocols. Behavioral tests occurred during the dark period. All procedures were approved by the Institutional Animal Care and Use Committee of the Louisiana State University Health Sciences Center and were in accordance with the National Institute of Health Guidelines.
Predator odor conditioned place aversion
To index rats for avoidance, animals underwent a 4-day conditioned place aversion (CPA) procedure, as previously described (Edwards et al., 2013) . Briefly, on the first day, rats were allowed 5 min to explore two conditioning chambers with distinct tactile (circles vs. grid rod floor) and visual (stripes vs. circles) cues. Sessions were videotaped and scored by an observer. Rats were assigned to predator odor stress and non-stress groups that were counterbalanced for magnitude of baseline preference for one chamber versus the other. For rats in the stress group, an unbiased and counterbalanced procedure was used to determine which chamber would be paired with predator odor exposure in individual rats. On the second day, rats were placed in one chamber without odor (neutral environment) for 15 min. On the third day, rats were placed in the opposite context for 15 min with a urine-soaked sponge (bobcat urine) placed under the floor of the chamber (predator odor environment), or no odor for control animals. On the fourth day, rats were again allowed to explore the two conditioning chambers in a 5 min video-recorded post-test. Avoidance was calculated as a difference score between post-conditioning time spent in odor-paired context and preconditioning time spent in odor-paired context. Rats that displayed a >10 s decrease in time spent in odor-paired chamber were classified as 'Avoiders'. Rats that displayed a <10 s decrease in time spent in the predator odor-paired chamber were classified as 'Non-Avoiders'. The 10 s cut-off for Avoiders and Non-Avoiders is consistent with previous publications from our lab (e.g., Edwards et al., 2013; Itoga et al., in press; Whitaker and Gilpin, 2015) . By not using a median split, our criterion for separating those two groups remains identical across studies. This 10 s cutoff has been used to show differences between groups in alcohol drinking (Edward et al., 2013) , nociception (Itoga et al., in press) , and the corticosterone response to stress (Whitaker and Gilpin, 2015) .
Immunohistochemical staining and counting in CRF cells in mPFC sub-regions
Rats (n ¼ 32) were deeply anesthetized with isoflurane, injected with chloral hydrate (35% 2 ml), and then intracardially perfused with 4% paraformaldehyde/0.1M borate buffer, pH 9.5 as previously described (Richardson et al., 2006) . Brains were post-fixed in the same fixative for 4 h at 4 ºC and submerged in the 20% sucrose/0.1M phosphate buffer, pH 7.4 for 48e72 hours before being snap-frozen in isopentane (2-methylbutane, Fisher Scientific) on dry ice. Brains were stored at À80 ºC, then coronally sectioned at 35 mm on a freezing microtome. Sections were stored in cryoprotectant (30% ethylene glycol, 30% sucrose and 1% polyvinyl pyrrolidone in 0.1M PBS) at À20 ºC until immunolabeling. Brain sections containing mPFC (from 3.72 mm to 2.52 mm relative to bregma) were sorted and labeled by rabbit anti-h/rCRF antiserum (1:5000, generously provided by Dr. Wylie Vale, Salk Institute) and biotinconjugated goat anti-rabbit antiserum (1:200, Vector Laboratories) using free-floating immunohistochemistry procedure (Karanikas et al., 2013) . CRF labeling signal was developed with 3,3'-diaminobenzidine (DAB) and nickel (Vector Laboratories), and sections were mounted on slides for microscopic analysis. Slides containing prefrontal sections were digitally scanned at high resolution (20X) under bright field illumination by Aperio ePathology (Leica Biosystems). Four coronal sections (spaced 350 mm apart) containing CRF immunoreactive (CRF-ir) cells and fibers were used to quantify CRF cell number in mPFC ( Fig. 2A) . The dmPFC contained anterior cingulate cortex (AC) and dorsal prelimbic cortex (PrL); the vmPFC contained ventral PrL and infralimbic cortex (IL) ( Fig. 2A) . Areas of interest were traced and measured using ImageScope software (Leica Biosystems), and all CRF-ir cells were counted within traced regions. Experimenters blind to the treatment group counted CRF-ir cells under 10X magnification of the slide images. The criteria for identifying CRF-ir cells were a clearly defined border of the soma and evidence of extended neurites.
CRF conditioned place aversion
Rats underwent a conditioned place aversion procedure similar to the one described by Cador et al., 1992 . Briefly, on day 1, rats underwent a 5 min video-recorded pre-test to explore two conditioning chambers with distinct tactile (circles vs. grid rod floor) and visual (stripes vs. circles) cues. Rat assignment to CRF dose groups was counterbalanced for context preference. Within dose groups, CRF infusions were paired with context for each rat in an unbiased counterbalanced design. On days 2, 4, and 6, rats were infused with sterile saline and immediately placed in one chamber for 15 min (neutral chamber). On days 3, 5, and 7, rats were infused with CRF (0, 0.05, 0.25, or 0.5 mg/0.5 ml per side) and immediately placed in the opposite chamber for 15 min (CRF chamber). It is important to note that each individual rat was repeatedly infused with the same CRF dose across conditioning days (i.e., between-subjects doseresponse). On day 8, rats underwent a 5 min video-recorded posttest to explore the two conditioning chambers. Avoidance was calculated as a difference score between post-conditioning time spent in CRF-paired context and pre-conditioning time spent in CRF-paired context.
Operant self-administration
Rats were trained to orally self-administer 10% w/v ethanol or water in a concurrent, two-lever, free-choice contingency that did not incorporate a sweet fading procedure, as previously described (Roltsch et al., 2014) . Rats were first given a single 24-hr period of access to 10% w/v ethanol vs. water in the home cage to prevent neophobia upon presentation of ethanol in operant boxes. Rats were then given a single 15-h operant session to learn to press a single lever for water (right lever; FR1) in the presence of ad libitum food on floor of operant chamber. Rats were then allowed one 3-h two-lever operant session for 10% w/v ethanol (right lever; FR1) vs. water (left lever; FR1), one 2-h session, then one 1-h session, followed by daily 30-min session for~15 days. All operant sessions after the initial 15-h session occurred in the absence of food. Rats with post-surgery baselines <10 alcohol presses in a 30-min session after vehicle infusion were excluded from further analysis.
Surgical procedures
On the day of surgery, rats were anesthetized with isoflurane and mounted in a stereotaxic frame (Stoelting). An incision was made, small bilateral holes were drilled into the skull, and stainless steel guide cannulae (26 gauge) lowered such that tips were 1 mm dorsal to vmPFC (AP þ 2.8, ML ± 3.1, DV À3.9 from the skull at an angle of 30 ) (Paxinos and Watson, 2005) . Guide cannulae were secured to the skull with metal screws and dental cement, the incision closed, and dummy cannulae inserted. Rats were allowed to recover and monitored daily for 1 week following surgery before initiating experimental procedures. Before sacrifice, animals were infused with Evans Blue to verify cannula placement (Fig. 3B,D) . Animals whose surgeries did not hit the target region were excluded from analysis.
Infusion procedure
Animals underwent sham infusions on days preceding infusion to acclimate them to the procedure. A Harvard instruments microinfusion pump was used for all infusions. Infusions were delivered via polyethylene tubing (PE20) connected to a 10 ml Hamilton syringe. Infusions were administered bilaterally at a rate of 0.2 ml/min over the course of 2.5 min via injectors (33ga, stainless steel) that extended 1 mm beyond the tip of the guide cannulae. Injection cannulae were left in the guide cannulae for an additional 1 min to allow for diffusion.
Drugs
The CRFR1 antagonist R121919 (generously supplied by Neurocrine, Inc.) was solubilized first in 1 M HCl (10% final volume) then diluted into 2-hydroxypropyl-cyclodextrin (HBC; Sigma-Aldrich, 20% wt/vol final concentration in distilled water) and backtitrated with NaOH to pH 4.5. CRF (Sigma Aldrich, St. Louis, MO) was solubilized in sterile saline. Fig. 1 illustrates the experimental timeline for Experiments 1e4 described below.
Experimental protocols
2.2.1. Experiment 1. Effect of predator odor stress on CRF-ir cell density in vmPFC and dmPFC Rats were exposed to predator odor stress, indexed for avoidance, and separated into Control (n ¼ 10), Non-Avoider (n ¼ 12), and Avoider (n ¼ 9). Nine days post-stress, rats were deeply anesthetized with isoflurane, injected with chloral hydrate (35% 2 ml), and then intracardially perfused. Brains were processed for CRF-ir cell density by immunohistochemical labeling as described in General methods.
Experiment 2. CRF-induced conditioned place aversion
Rats (N ¼ 32) were implanted with cannulae 1 mm dorsal to vmPFC bilaterally and secured to the skull. After one week of recovery, rats underwent the CRF CPA procedure described in General methods.
Experiment 3. Effect of CRFR1 antagonism on post-stress avoidance and alcohol drinking
Rats were tested for baseline ethanol self-administration. Upon stabilization of operant responding, cannulae were surgically implanted 1 mm dorsal to the vmPFC bilaterally and secured to the skull. After one week of recovery, rats were re-tested for baseline self-administration with vehicle infusions, then exposed to predator odor stress, indexed for avoidance, and separated into Control (n ¼ 12), Non-Avoiders (n ¼ 15), and Avoiders (n ¼ 19). On poststress days 2, 5, 8, and 11, rats were allowed to self-administer alcohol for 30 min, as described above. On post-stress day 12, rats were again tested for avoidance of the predator-odor paired chamber. Five minutes prior to each test, rats received intra-vmPFC infusion of vehicle (20% HBC, 0.5 ml) or R121919 (0.25 mg/0.5 ml); each rat only received vehicle or R121919 throughout the experiment.
Statistical analysis
Data are shown as mean ± SEM with the number of animals in each experiment indicated in Fig. 1 . In Experiment 1, CRF-ir cell density was analyzed with a mixed-design ANOVA where stress history was a between factor and bregma was a within factor. Averaged CRF-ir cell number across 4 sections was analyzed where stress was the treatment factor. In Experiment 2, avoidance of CRFpaired chamber was analyzed with a one-way ANOVA where drug dose was the treatment factor, and with trend analysis to determine whether the linear (change in dependent variable as a function of change in the independent variable) and/or quadratic (rate of change in the dependent variable as a function of change in the independent variable) components of responding were significantly affected by CRF dose. CRFR1 antagonist effects on avoidance were analyzed with three-way RM ANOVA where stress history and R121919 drug dose were the treatment factors and time (day 1 vs. day 12 post-stress) was the within-subjects factor. Differences in ethanol self-administration over time were analyzed with a threeway RM ANOVA where stress history and drug dose were the between-subject factors and time was the within-subjects factor. Post hoc analysis with the Tukey's HSD Test was used when appropriate. Statistical significance was set as p 0.05.
Results

Predator odor stress increases CRF immunoreactivity in the vmPFC but not dmPFC of avoiders
In Experiment 1, Avoiders exhibited higher density of CRF-ir cells relative to Non-Avoiders and unstressed Controls 9 days post-stress in the vmPFC (F[2,285.698], p ¼ 0.008), but not in dmPFC (F[2,28] ¼ 1.550, p ¼ 0.230) (Fig. 2B, D) . CRF cell density in vmPFC and dmPFC was positively correlated with avoidance of the predator odor-paired chamber 24 h post-stress (dmPFC, R 2 ¼ 0.18, (Fig. 2C, E) . Because there was no significant change in CRF immunoreactivity in the dmPFC of stressed rats, behavioral pharmacology studies were only conducted in the vmPFC.
CRF in vmPFC produces conditioned place aversion
In Experiment 2, rats underwent a CPA test using intra-vmPFC CRF infusion as the unconditioned stimulus. Compared to vehicleinfused rats, CRF-infused rats spent less time in the drug-paired chamber (F[3,28] ¼ 2.862; p ¼ 0.054; Fig. 3A) . Quadratic trend analysis revealed that the amount of time spent avoiding the CRFpaired chamber was related to dose of CRF, with lower doses producing more avoidance than higher doses (p ¼ 0.054). (Fig. 2) . Experiments 2 and 3 were behavioral experiments in which animals received brain site-specific pharmacology (Figs. 3 and 4) .
CRFR1 antagonism in vmPFC reduces avoidance of stresspaired context
In Experiment 3, rats underwent a CPA procedure 1 d post-stress for indexing of avoidance behavior and again 12 d post-stress with or without antagonism of CRFR1s in the vmPFC. A 1-way ANOVA of day 1 avoidance showed that Avoiders spent significantly more time avoiding the predator odor-paired chamber compared to NonAvoiders and Controls (Controls À5.94 þ 11.36 s; Non-Avoiders 25.24 þ 9.5 s; Avoiders À39.25 þ 6.21 s compared to preconditioning baseline) (F[2,43] ¼ 16.45; p < 0.01). A separate, 2-way ANOVA of day 12 avoidance revealed a main effect of stress on the amount of time spent avoiding the predator odor paired chamber. On day 12 post-stress, Avoiders spent significantly less time than Non-Avoiders in the predator odor-paired chamber (F [1,24] ¼ 18.06; p < 0.01) (Fig. 3C) , as would be expected based on the model and past reports from our lab (Whitaker and Gilpin, 2015) . Based on the a priori hypothesis that CRFR1 antagonism would reduce avoidance, we analyzed day 12 (i.e., after R121919 treatment) avoidance scores in Avoider rats using a two-samples ttest where R121919 dose was the between-subjects factor. This analysis revealed that R121919 significantly reduced avoidance in Avoiders relative to vehicle-treated controls (t(17) ¼ 2.09; p ¼ 0.026) (Fig. 3C) . A separate two-samples t-test indicated that R121919 did not affect avoidance behavior in Non-Avoiders 12 days post-stress (t(10) ¼ 0.4994; p ¼ 0.523).
CRFR1 antagonism does not affect alcohol self-administration
In Experiment 3, rats were trained to self-administer 10% ethanol. The pre-surgery baseline was 42.08 ± 1.76 presses in a 30 min session. After surgery, the average lever presses for ethanol in a 30 min session was 27.92 ± 1.62. This decrease in ethanol self-administration was due either to surgery, the introduction of pre-operant sham infusions, or both. Once postsurgery operant responding stabilized, rats were stressed and then were allowed to self-administer alcohol on days 2, 5, 8, and 11 post-stress after infusion of either vehicle or R121919 into the vmPFC (Fig. 4) . When operant response data were analyzed as percent of baseline for each rat (Fig. 4) , there was a trend for Avoiders to respond more for alcohol than the other two groups after predator odor exposure (F[2,40] ¼ 2.99; p ¼ 0.06). A 3-way RM ANOVA revealed no significant increases in raw alcohol drinking across days after stress. There was no significant main effect of R121919 treatment on self-administration (F[1,40] ¼ 0.08; p ¼ 0.77), nor was there a significant interaction effect (F[2,40] ¼ 1.28; p ¼ 0.29).
Discussion
In this study, we tested the role of CRF in the vmPFC in mediating predator odor stress-induced avoidance and escalation of alcohol drinking. We demonstrated that 1) after predator odor stress, Avoiders have higher CRF cell density in the vmPFC, but not the dmPFC, that is positively correlated with avoidance of the predator odor-paired chamber 24 h after stress, 2) CRF infused into the vmPFC produces conditioned avoidance of a paired context, 3) CRFR1 antagonism in vmPFC reduces avoidance behavior, and The present study demonstrates a role for CRF in the vmPFC in stress-induced avoidance behavior. After exposure to predator odor stress, Avoiders exhibited higher CRF cell density 9 days post-stress. Based on the spread of the data in Avoiders relative to Controls, and because it is unlikely that random assignment of animals into stress and controls groups would select for animals with different numbers of CRF-ir cells in vmPFC, it is reasonable to assume that the differences in CRF-ir cell counts are not pre-existing, but are caused by exposure to the predator odor. Increases in density of CRF-ir cells within the vmPFC were correlated with more time spent avoiding the predator odor-paired chamber 24 h post-stress, suggesting that more avoidance is related to higher CRF density in the vmPFC. We did not measure CRF release into the synapse, but it is notable that chronic CRFR1 antagonism in the vmPFC reduced avoidance behavior in Avoiders (Fig. 3B) . Overall, this suggests that avoidance of a stress-paired context may be mediated, at least in part, by CRF signaling in the vmPFC. This result agrees with prior data showing that exposure to a traumatic stress reminder increases ERK phosphorylation, a marker and mediator of neuronal activity downstream of CRFR1 signaling (Meng et al., 2011) , in vmPFC of Avoiders compared to Non-Avoiders (Edwards et al., 2013) .
Here, we show that CRF in the vmPFC is aversive using a conditioned place aversion paradigm. We demonstrate that low CRF doses (0.05 mg/side) produce conditioned avoidance of a CRFpaired chamber compared to vehicle, while higher doses of CRF (0.25 and 0.5 mg/side) produced less avoidance. According to the literature, different doses of CRF in the mPFC have different effects on anxiety-like behavior in rodents. Specifically, low doses (0.02e0.05 mg/side) produce anxiety-like behavior (Jaferi and Bhatnagar, 2007; Ohata and Shibasaki, 2011) , while high doses (0.2e1.0 mg/side) of CRF infused into the mPFC are anxiolytic (Ohata and Shibasaki, 2011; Pentkowski et al., 2013) . In our study, the lowest CRF dose (0.05 mg/side), which matches anxiogenic CRF doses in the literature, produced the strongest avoidance of the CRF-paired chamber. Both the anxiogenic and anxiolytic effects of vmPFC CRF are thought to be mediated by activation of CRFR1 on glutamatergic pyramidal cells, because there are no CRFR2 in the vmPFC (Chalmers et al., 1995) . It is possible that low and high CRF doses initiate different CRFR1 signaling cascades to produce opposite behavioral responses: for example, it has been suggested that the anxiogenic actions of low CRF doses may be mediated by a protein kinase A-dependent mechanism (Miguel et al., 2014) , whereas the anxiolytic-like actions of high CRF doses may be mediated via a protein kinase C-dependent mechanism (Tan et al., 2004) . Interestingly, CRFR1 antagonism in vmPFC reduced avoidance behavior in stressed rats, suggesting that physiological levels of CRF in vmPFC promote avoidance, and perhaps anxiety-like behavior. Further studies will determine the cellular mechanisms whereby CRF-CRFR1 signaling in vmPFC produces aversion.
The vmPFC projects to sub-cortical brain regions that control anxiety, fear, and drug addiction. The vmPFC facilitates hypothalamic stress responses and may regulate long-lasting anxiety through its indirect projections to the PVN and direct projections to bed nucleus of the stria terminalis, respectively (Radley et al., 2006; Motzkin et al., 2015b) . The vmPFC also sends dense projections to the basomedial amygdala and/or the intercalated cells of the amygdala to mediate fear extinction (Adhikari et al., 2015; Keifer et al., 2015; Sotres-Bayon and Quirk, 2010) . In humans, damage to the vmPFC leads to disinhibition of the amygdala, which has been hypothesized to contribute to PTSD symptoms (Motzkin et al., 2015a) . These studies all support a role for dysregulation of the vmPFC in traumatic stress and anxiety disorders.
We also tested whether CRF-CRFR1 signaling in the vmPFC mediates escalation of alcohol drinking after stress. After stress, there was a trend toward stress group differences in alcohol selfadministration (p ¼ 0.06). Previously we demonstrated that Avoider rats self-administer more alcohol than Non-Avoiders and unstressed Controls (Edwards et al., 2013) . The current study may have failed to reach significance due to the stress caused by the drug infusion procedure 5 min before alcohol self-administration, despite the inclusion of post-surgery sham and vehicle infusions to acclimate animals to the infusion procedure. CRFR1 antagonism in the vmPFC did not affect alcohol drinking. Although our data do not demonstrate a role for vmPFC CRF-CRFR1 signaling in poststress alcohol drinking, the vmPFC is important for extinction and relapse of alcohol-seeking behavior. For example, the vmPFC inhibits drug-seeking following extinction (Van den Oever et al., 2010; Peters et al., 2008) , and enhancement of mGluR5 signaling in the infralimbic cortex facilitates extinction of alcohol responding in rats (Gass et al., 2014) . Pfarr et al. (2015) identified a specific vmPFC neuronal ensemble critical for inhibiting alcohol-seeking behavior after cue-induced reinstatement, whereas complete vmPFC inactivation does not affect extinction or cue-induced reinstatement of alcohol-seeking behavior (Willcocks and McNally, 2013; Pfarr et al., 2015) . Our data suggest that CRF-CRFR1 signaling in vmPFC is not a critical mediator of nonextinguished alcohol self-administration after stress.
Overall, this study demonstrates a role for CRF-CRFR1 signaling in the vmPFC in mediating conditioned avoidance of stimuli paired with predator odor stress. In addition, we report that CRF-CRFR1 signaling in the vmPFC is necessary for avoidance of a predator odor-paired chamber but not for escalation of alcohol drinking following a traumatic stress.
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